Abstract. Oral squamous cell carcinoma (OSCC) is one of the most common types of head and neck neoplasms in the world. Patients diagnosed with OSCC exhibit a poor prognosis. WW domain-containing oxidoreductase (WWOX), as a candidate tumor-suppressor gene, is involved in the genesis and progression of tumors. The deletion of the WWOX gene has been identified in OSCC and oral leukoplakia, but the function and mechanism of WWOX in OSCC remain unknown. Therefore, the present study investigated the role of WWOX in oral squamous carcinoma cells. The results revealed that an elevation of WWOX expression had an inhibitory effect on the growth of three types of oral squamous carcinoma cells, with the most evident effect occurring in Tca8113 cells. Also, in the Tca8113 cells, WWOX overexpression significantly inhibited colony formation, and induced apoptosis and cell cycle arrest. Microarray analysis, reverse transcription-quantitative polymerase chain reaction and western blotting methods detected that WWOX overexpression contributed to the differential expression of the genes involved in mediating the extracellular-signal regulated protein kinase/mitogen-activated protein kinase (ERK/MAPK) signaling pathway. These results suggest that the tumor-suppressor function of the WWOX gene may be associated with the modulation of the ERK/MAPK signaling pathway, thus providing a novel target for OSCC therapy.
Introduction
Each year, ~480,000 new cases of oral cancer are diagnosed worldwide, the majority of which are squamous cell carcinoma (1, 2) . Globally, oral squamous cell carcinoma (OSCC) has become the most commonly diagnosed type of head and neck neoplasm (3) . Despite improvements in tumor treatments, the 5-year survival rate for OSCC has remained ~50% during the last decades (4) . In the treatment of OSCC, surgery and radiation can cause severe functional impairment, while the efficacy of chemotherapeutic agents is limited by acquired resistance and drug side effects (5) . As a result, the development of new molecular targets for the prevention and treatment of OSCC has become an urgent matter.
WW domain-containing oxidoreductase (WWOX) has been identified as a tumor-suppressor gene that spans the chromosomal fragile site FRA16D. Lost or reduced expression of the WWOX gene commonly presents in numerous types of neoplasms, including breast, prostate, ovary, lung and oral cancer (6) (7) (8) . A reduced expression of WWOX has been observed in cases of OSCC and oral leukoplakia, which are prevalent precancerous lesions (8, 9) . By contrast, normal transcriptomes and proteins of WWOX were observed to be expressed in normal mucosa (9, 10) . Therefore, the present study speculated that WWOX deficiency in oral squamous carcinoma cells may contribute to oral carcinogenesis. However, the function and precise molecular mechanism of WWOX in OSCC remain unclear.
The present study aimed to detect, in vitro, the effect of WWOX overexpression on cell growth, apoptosis and cell cycle distribution in oral squamous carcinoma cells. The present study also used a microarray assay, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis and western blotting to investigate the expression of genes that are modulated by WWOX, in order to elucidate the underlying molecular mechanisms of the antitumor effect of WWOX. GAG GAT CCC CGG GTA CCG GTC GCC  ACC ATG GCA GCG CTG CGC TAC-3' and reverse, 5'-TCC  TTG TAG TCC ATA CCG CCG GAC TGG CTG CCA AG-3' . The WWOX complementary DNA (cDNA) was subcloned into a pGV287-LV lentivirus vector, purchased from Shanghai Genechem Co., Ltd. (Shanghai, China). The positive clone, pGV287-LV-WWOX, was selected through sequencing. The reconstructed lentivirus vector, and two helper vectors, pHelper1.0 and pHelper2.0 (Jikai Gene Biochemical Co., Ltd., Shanghai, China), were produced in the 293T packaging cell line. The cells were placed in 6-well plates and grown to 30% confluency prior to being infected with the virus (~109 TU/ml, multiplicity of infection=20). The medium was replaced at 16 h post-infection and the cells were cultured as normal. RT-qPCR and western blotting were then used to confirm the expression of WWOX, according to the protocol described below.
Materials and methods

Cell
Cell proliferation assay. An MTT assay was used to assess cell proliferation. The Tca8113 cells, the Tca8113 cells transfected with an empty vector and the Tca8113 cells transfected with the reconstructed vector were separately plated in 96-well plates with a density of 2,000 cells/well and incubated at 37˚C for 1-5 days. A total of 20 µl MTT (5 mg/ml) was added to each well and incubated for 4 h on days 1 to 5. Each day, prior to incubation, a total of 20 µl MTT (5 mg/ml) was added to each well and the plates were incubated for 4 h. The crystals formed were subsequently dissolved in dimethyl sulfoxide. The optical density was assessed at 490 nm (OD 490 ). Cell proliferation activity was analyzed using the mean OD 490 values for each well.
Colony formation assay. Subsequent to infection, the cells were seeded in 6-well plates at a density of 800 cells/plate and cultured at 37˚C for 14 days until visible colonies appeared. The cells were stained with methyl violet prior to end of the incubation and the number of colonies was counted under a light microscope (Olympus Corporation, Tokyo, Japan). (11) . Genes that were significantly differentially expressed in cells, with or without WWOX overexpression, were selected based on exhibiting P<0.05 and a 1.5-fold-change (FC). The Reactome FI Cytoscape Plugin (www.reactome.org) was used to perform function pathway analysis according to the protocol of the manufacturer.
RT-qPCR.
Each reaction was carried out in triplicate. Total RNA separately from the Tca8113 cells with empty vectors and the Tca8113 cells from with WWOX overexpression was isolated from the cultured cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) for cDNA synthesis. Reverse transcription was performed for one cycle under the following conditions: 70˚C for 10 min; 42˚C for 1 h; then 70˚C for 10 mißn using the Reverse Transcription System (Promega Corporation, Madison, WI, USA). qPCR was performed using a StepOneä Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA) with the One Step SYBR PrimeScript RT-PCR kit II (Takara Bio, Inc., Otsu, Japan). The relative expression of all investigated genes was calculated using the 2 -ΔΔCq (12) method subsequent to the normalization of the reference gene GAPDH. The primer sequences were as follows: GAPDH forward, 5'-TGA CTT CAA CAG CGA CAC CCA -3' and reverse, 5'-CAC CCT GTT GCT GTA GCC AAA-3'; WWOX forward, 5'-CCA ACC ACC CGG CAA AGA TA-3' and reverse, 5'-AATGCTGCACGCTACGGAG-3'; dual specificity phosphatase (DUSP) 5 forward, 5'-TCC TCA CCT CGC TAC TCG-3' and reverse, 5'-ACA TCC ACG CAA CAC TCAG-3'; DUSP6 forward, 5'-GAA CTG TGG TGT CTT GGT ACA TT-3' and reverse, 5'-GTT CAT CGA CAG ATT GAG CTT CT-3'; nuclear receptor subfamily 4 group A member 1 (NR4A1) forward, 5'-TCA TGG ACG GCT ACA CAG-3' and reverse, 5'-GTG GCT GAG GAC GAG GATG-3'; mitogen-activated protein kinase kinase (MAP2 K) 5 forward, 5'-ACT GAC GAG CGG TGG AC-3' and reverse, 5'-GTC GGA AGG TTC TGGA-3'; and fibroblast growth factor receptor 2 (FGFR2) forward, 5'-GGT GGC TGA AAA ACG GGA AG-3' and reverse, 5'-AGA TGG GAC CAC ACT TTC CATA-3'. PCR was performed under the following conditions: 95˚C for 30 sec; 40 cycles of 95˚C for 5 sec and 60˚C for 30 sec.
Western blot analysis. Cell proteins were separated using 10% SDS-PAGE and transferred to a polyvinylidene fluoride membrane subsequent to cell protein concentration being quantified with a Bio-Rad assay kit (cat. no. 5000002; Bio-Rad Laboratories, Inc., Hercules, CA, USA). The membranes were blocked in 5% non-fat milk at room temperature for 1 h and incubated with the primary antibodies (all antibodies were purchased from Santa Cruz Biotechnology, Inc., Dallas, 
Results
Lentivirus infection enables the overexpression of the WWOX gene in Tca8113 cells.
By comparing the relative WWOX messenger RNA (mRNA) levels in the oral cancer Tca8113, CAL27 and FaDu cell lines, the present study observed that Tca8113 cells exhibited the lowest expression of the WWOX gene (P<0.05; Fig. 1A ). Subsequent to the Tca8113 cells being infected with the lentivirus plasmid pGV287-LV-WWOX, the mRNA expression of the WWOX gene was >90.593-fold, significantly greater than that detected in the cells infected with the empty vector pGV287-LV (P<0.05; Fig. 1B ). Western blotting detected elevated levels of WWOX protein expression in Tca8113 cells with WWOX overexpression (Fig. 1C) .
Overexpression of the WWOX gene inhibits cell growth in vitro.
To investigate the effect of WWOX on cell growth, WWOX overexpression plasmids were transfected into Tca8113, CAL27 and FaDu cells. WWOX overexpression inhibited cell proliferation as determined by the MTT method. This inhibition was most prevalent in the Tca8113 cells (P<0.05; Fig. 2A and B) . The colony formation assay also revealed similar inhibition in the Tca8113 cells (P<0.05; Fig. 2C ). Furthermore, flow cytometry assays revealed a significant increase in apoptosis and G0/G1-phase population subsequent to transfection with the WWOX overexpression plasmids (P<0.05; Fig. 2D and E) .
Overexpression of the WWOX gene modulates several key pathways in Tca8113 cells, as determined by global gene expression analysis.
To investigate the mechanism of WWOX tumor-suppressor function, the present study compared the transcriptomes of cells transfected with the WWOX gene with those transfected with an empty vector. The present study used the Affimetrix Human Gene 1.0 ST Array to identify 347 transcriptomes that were significantly differentially expressed, of which, 171 genes were upregulated and 176 genes were downregulated, based on an FC >1.5 and P<0.05 threshold in Tca8113 cells with WWOX overexpression compared with the findings in the associated control (Fig. 3A) . Through a functional analysis of genes using the Reactome Functional Interaction network, the present study demonstrated that WWOX overexpression modulated the activation of certain key signaling pathways, including the mitogen-activated protein kinase (MAPK) signaling pathway ( Fig. 3B and C) .
Overexpression of the WWOX gene regulates the expression of certain genes involved in modulating MAPK signaling.
The present study screened selected genes associated with MAPK signaling. Utilizing global gene expression analysis to determine absolute FC subsequent to the overexpression of WWOX, the present study identified that the absolute FC of DUSP5, DUSP6, NR4A1 and MAP2K5 increased, while the absolute FC of FGFR2 decreased, compared with that of the Tca8113/vector control group (all P<0.05; Fig. 4A ). Subsequently, the mRNA and protein expression levels of the genes were examined by RT-qPCR and western blotting, yielding results that were for the majority of genes consistent with the initial findings of the present study (P<0.05; Fig. 4B and C), indicating the upregulation of DUSP5, DUSP6, NR4A1 and MAP2K5, and the downregulation of FGFR2, with respect to mRNA and protein levels.
Discussion
WWOX has been identified as a gene located on a chromosomal fragile site, and deficiency/deletion with respect to the expression of the gene is common in various types of carcinoma (6) . Reduced expression was also demonstrated in OSCC and oral precancerous lesions subsequent to examination with PCR and immunohistochemistry (8-10). Reduced expression of WWOX contributed to tumor development and progression, and exogenous WWOX expression significantly suppressed tumor growth (13, 14) . Qu et al (15) revealed that the reconstitution of WWOX inhibited cell proliferation and induced apoptosis, while the knockdown of WWOX resulted in the opposite effect in cervical cancer cells. Lin et al (16) concluded that WWOX suppressed prostate cancer cell progression by inducing cell cycle arrest in the G1 phase. The present study investigated the effect of WWOX overexpression on cell growth in oral squamous carcinoma cells, and the results are consistent with the findings of previous studies with respect to the WWOX gene inhibiting cell proliferation, and promoting apoptosis and cell cycle arrest. To investigate the underlying tumor-suppression mechanism of the WWOX gene, the present study used microarray analysis to evaluate the genetic changes exhibited in Tca8113 cells subsequent to WWOX overexpression.
To investigate the underlying tumor-suppression mechanism of the WWOX gene, the present study analyzed the genetic change of Tca8113 cells following WWOX overexpression by microarray analysis, and noticed an increase in the expression of DUSP5, DUSP6, NR4A1 and MAP2K5, and a decrease in the expression of FGFR2. These genes are closely associated with the extracellular-signal regulated protein kinase (ERK)/MAPK signaling pathway, and mediate various biological events involved in cell proliferation, differentiation and survival (17) .
DUSP5 and DUSP6 are members of the MAPK phosphatase family (18) . Okudela et al (19) , Li et al (20) and Nunes-Xavier et al (21) observed that DUSP5 and DUSP6 act as negative mediators in the regulation of ERK1/2 phosphorylation and cell growth in tumor cells. Wang et al (18) indicated that, in corneal epithelial cells, DUSP6 overexpression specifically prevented the formation of phosphorylated ERK1/2 and slowed cell growth, whereas DUSP5 knockdown was observed to enhance ERK1/2 phosphorylation and cell growth. The authors therefore concluded that DUSP5 and DUSP6 serve a role in the negative feedback regulation of ERK/MAPK signaling when their expression is upregulated through the activation of the ERK/MAPK signaling pathway. The present study demonstrated that, subsequent to WWOX overexpression, the increased expression of DUSP5 and DUSP6 is accompanied by the inhibition of Tca8113 cell growth. Therefore, the present study hypothesizes that WWOX overexpression activates the ERK/MAPK signaling pathway, and upregulates the expression of DUSP5 and DUSP6. Conversely, DUSP5 and DUSP6 reduce ERK phosphorylation, and suppress the growth of Tca8113 cells.
NR4A1, also referred to as Nur77, is a member of the nuclear receptor subfamily 4, group A, and can be activated via a cascade involving MAP2K5, MAPK7 and NR4A1, which is also dependent on the ERK/MAPK signaling pathway (22) . In OSCC, NR4A1 activated through the MAPK signaling pathway can induce apoptosis (23) . The present study demonstrated that the combination of the upregulation of NR4A1 and MAP2K5 increased the level of apoptosis subsequent to WWOX overexpression in Tca8113 cells. Previous studies identified that NR4A1 induces apoptosis by associating with B-cell lymphoma 2 and initiating the release of cytochrome c (23,24). Zhang et al (25) reported that the ectopic overexpression of WWOX also induces a release of cytochrome c from the mitochondria. As a result, the present study hypothesizes that the overexpression of WWOX upregulates the expression of MAP2K5 and NR4A1 by activating the ERK/MAPK signaling pathway, and induces apoptosis in Tca8113 cells through the release of cytochrome c.
FGFR2 is a tyrosine kinase receptor that is crucial with respect to controlling tumor proliferation, angiogenesis, migration and survival (26) . Katoh and Nakagama (27) demonstrated that the expression of FGFR2 was amplified in breast and gastric cancer. In the colorectal cancer NCI-H716 cell line, which exhibits a high expression of FGFR2, the inhibition of FGFR2 by small molecule inhibitors or FGFR2 short hairpin (sh)RNA was shown to decrease cell viability (28) . In pancreatic cancer, tumor cells with FGFR2-shRNA transfection exhibited attenuated proliferation rates, migration and invasion levels, and a reduced level of phosphorylation of ERK compared with that of the control cells (29) . These findings demonstrate that the inhibition of FGFR2 contributes to the suppression of cell proliferation and ERK phosphorylation. In the present study, a reduced expression of FGFR2 and the inhibition of growth in Tca8113 cells were also observed when WWOX was overexpressed.
In summary, the overexpression of the WWOX gene in Tca8113 cells suppressed cell growth, and induced apoptosis and cell cycle arrest. This tumor suppression is associated with a modulation of the expression of genes that mediate the ERK/MAPK signaling pathway. The conclusions of the present study regarding the tumor-suppressor functions of the WWOX gene in a diagrammatic sketch are presented in Fig. 5 . Targeting WWOX may be an effective method for the treatment of oral cancer.
